AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
1.660
0.00 (0.00%)
Apr 25, 2025, 10:49 AM EDT - Market open
AC Immune Market Cap
AC Immune has a market cap or net worth of $164.25 million as of April 25, 2025. Its market cap has decreased by -40.88% in one year.
Market Cap
164.25M
Enterprise Value
-12.39M
1-Year Change
-40.88%
Ranking
Category
Stock Price
$1.66
Market Cap Chart
Since September 23, 2016, AC Immune's market cap has decreased from $867.50M to $164.25M, a decrease of -81.07%. That is a compound annual growth rate of -17.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 158.60M | -41.17% |
| Dec 31, 2024 | 269.60M | -36.36% |
| Dec 29, 2023 | 423.60M | 145.85% |
| Dec 30, 2022 | 172.30M | -52.25% |
| Dec 31, 2021 | 360.80M | -2.88% |
| Dec 31, 2020 | 371.50M | -35.46% |
| Dec 31, 2019 | 575.60M | 6.20% |
| Dec 31, 2018 | 542.00M | -25.42% |
| Dec 29, 2017 | 726.70M | 1.07% |
| Dec 30, 2016 | 719.00M | -17.12% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.03B |
| UnitedHealth Group | 386.16B |
| Johnson & Johnson | 372.77B |
| AbbVie | 319.07B |
| Novo Nordisk | 276.96B |
| Abbott Laboratories | 224.40B |
| AstraZeneca | 215.41B |
| Novartis AG | 208.99B |